Inventor

RIETHER DORIS

DE49 patents

⚠️ This page may combine multiple inventors who share the name “RIETHER DORIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RIETHER DORIS

BOEHRINGER INGELHEIM INT

Compounds which modulate the CB2 receptor

Compounds which selectively modulate the CB2 receptor

Therapeutic uses of compounds which selectively modulate the CB2 receptor

Therapeutic uses of compounds which selectively modulate the CB2 receptor

Compounds which modulate the CB2 receptor

Compounds which modulate the CB2 receptor

Compounds which selectively modulate the CB2 receptor

Azetidine 2-carboxamide derivatives which modulate the CB2 receptor

N-[(pyrimidinylamino)propanyl]-and N[(pyrazinylamino)proppanyl]arylcarboxamides

Compounds which modulate the CB2 receptor

N-(2,2-difluoroethyl)-N-[(pyrimidinylamino)propanyl]arylcarboxamides

N-[(pyrimidinylamino)propanyl]-,n-[pyridylamino)propanyl]- and n-[(pyrazinylaminol)propanyl]arylcarboxamides

N-[(pyridyloxy)propanyl]benzamides

N-[(heteroaryloxy)propanyl]heteroaryl carboxamides as antagonists of orexin subtype 1 receptor activity

N-[(Pyrimidinylamino)propanyl]-and N-[(Pyridinylamino)-propanyl]arylcarboxamides

N-[(pyrazinyloxy)propanyl]benzamides as antagonists of orexin subtype 1 receptor activity

N-[(pyrimidinyloxy)propanyl]benzamides

Compounds which selectively modulate the CB2 receptor

BARTOLOZZI ALESSANDRA

Compounds which selectively modulate the CB2 receptor

Oxadiazole inhibitors of leukotriene production

Compounds which selectively modulate the CB2 receptor

Heterocyclic compounds which modulate the CB2 receptor

Heterocyclic compounds as inhibitors of leukotriene production

Oxadiazole inhibitors of leukotriene production

Oxadiazole inhibitors of leukotriene production

Compounds which modulate the CB2 receptor

Oxadiazole inhibitors of leukotriene production

CENTREXION THERAPEUTICS CORP

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

(cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

BERRY ANGELA

Compounds which modulate the CB2 receptor

Pyrrolidine compounds which modulate the CB2 receptor

Compounds which modulate the CB2 receptor

Compounds which modulate the CB2 receptor

Compounds which modulate the CB2 receptor

BOEHRINGER INGELHEIM PHARMA

Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof

Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof

BEKKALI YOUNES

Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof

Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof

GRUNDL MARC

Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C

ERMANN MONIKA

Tetrazole compounds which selectively modulate the CB2 receptor

REGAN JOHN

Sulfone compounds which modulate the CB2 receptor

RIETHER DORIS

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

HICKEY EUGENE RICHARD

Sulfonyl compounds which modulate the CB2 receptor

CIRILLO PIER FRANCESCO

Amine and ether compounds which modulate the CB2 receptor

GOTTSCHLING DIRK

Pyrazolopyrimidines as metabotropic glutamate 5 receptor antagonists